Literature DB >> 7078580

Treatment of inborn errors of urea synthesis: activation of alternative pathways of waste nitrogen synthesis and excretion.

M L Batshaw, S Brusilow, L Waber, W Blom, A M Brubakk, B K Burton, H M Cann, D Kerr, P Mamunes, R Matalon, D Myerberg, I A Schafer.   

Abstract

Children with inborn errors of urea synthesis accumulate ammonium and other nitrogenous precursors of urea, leading to episodic coma and a high mortality rate. We used alternative pathways for the excretion of waste nitrogen as substitutes for the defective ureagenic pathways in 26 infants. These pathways involve synthesis and excretion of hippurate after sodium benzoate administration, and of citrulline and argininosuccinate after arginine supplementation. The children were treated for seven to 62 months; 22 survived. The mean plasma level of ammonium ( +/- S.E.) was 36 +/- 2 mumol per liter, and that of benzoate was 1.5 +/- 1.0 mg per deciliter. Alternative pathways accounted for between 28 and 59 per cent of the total "effective" excretion of waste nitrogen. Nineteen infants had normal height, weight, and head circumference, and 13 had normal intellectual development. Activation of alternative pathways of waste nitrogen excretion can prolong survival and improve clinical outcome in children with inborn errors of urea synthesis.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7078580     DOI: 10.1056/NEJM198206103062303

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  73 in total

1.  Increased intracranial pressure in a neonate with citrullinaemia.

Authors:  J L Wayenberg; D Vermeylen; E Gerlo; A Pardou
Journal:  Eur J Pediatr       Date:  1992-02       Impact factor: 3.183

Review 2.  Ornithine carbamoyl transferase deficiency: findings, models and problems.

Authors:  C Bachmann
Journal:  J Inherit Metab Dis       Date:  1992       Impact factor: 4.982

Review 3.  Diagnosis and management of inborn errors of metabolism.

Authors:  J E Wraith
Journal:  Arch Dis Child       Date:  1989-10       Impact factor: 3.791

4.  Benzoate treatment and the glycine index in nonketotic hyperglycinaemia.

Authors:  J L K Van Hove; K Vande Kerckhove; J B Hennermann; V Mahieu; P Declercq; S Mertens; M De Becker; P S Kishnani; J Jaeken
Journal:  J Inherit Metab Dis       Date:  2005       Impact factor: 4.982

5.  Chronic coagulopathy in a patient with argininosuccinase deficiency.

Authors:  E V Bawle; I Warrier
Journal:  J Inherit Metab Dis       Date:  1991       Impact factor: 4.982

6.  A zebrafish model of hyperammonemia.

Authors:  B Feldman; M Tuchman; L Caldovic
Journal:  Mol Genet Metab       Date:  2014-07-10       Impact factor: 4.797

Review 7.  Brain imaging in urea cycle disorders.

Authors:  Andrea Gropman
Journal:  Mol Genet Metab       Date:  2010-02-13       Impact factor: 4.797

8.  Ammonia control in children ages 2 months through 5 years with urea cycle disorders: comparison of sodium phenylbutyrate and glycerol phenylbutyrate.

Authors:  Wendy Smith; George A Diaz; Uta Lichter-Konecki; Susan A Berry; Cary O Harding; Shawn E McCandless; Cindy LeMons; Joe Mauney; Klara Dickinson; Dion F Coakley; Tristen Moors; Masoud Mokhtarani; Bruce F Scharschmidt; Brendan Lee
Journal:  J Pediatr       Date:  2013-01-13       Impact factor: 4.406

9.  Chronic vomiting in a case of citrullinaemia detected after treatment by total parenteral nutrition.

Authors:  A Benque; G Bommelaer; G Rozental; P Cales; L Cathelineau; D Pham Dinh; A Ribet
Journal:  Gut       Date:  1984-05       Impact factor: 23.059

10.  Effects of sodium benzoate, a widely used food preservative, on glucose homeostasis and metabolic profiles in humans.

Authors:  Belinda S Lennerz; Scott B Vafai; Nigel F Delaney; Clary B Clish; Amy A Deik; Kerry A Pierce; David S Ludwig; Vamsi K Mootha
Journal:  Mol Genet Metab       Date:  2014-11-15       Impact factor: 4.797

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.